Antibiotic inhibitors of the peptidyl transferase center. 1. Clindamycin as a composite analogue of the transfer RNA fragments L-Pro-Met and the D-ribosyl ring of adenosine

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 1, 1998, Pages 87-92

  Fitzhugh, Anthony L ^a  

^a BioCipher BF   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ANTIBIOTIC AGENT; CLINDAMYCIN; PEPTIDYLTRANSFERASE; TRANSFER RNA;

ARTICLE; COMPUTER; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; MOLECULAR MODEL; NONHUMAN; PROTEIN SYNTHESIS; STRUCTURE ACTIVITY RELATION;

CLINDAMYCIN; DRUG DESIGN; ENZYME INHIBITORS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PEPTIDYL TRANSFERASES; PROTEIN SYNTHESIS INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

PROKARYOTA;

EID: 0032488583     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)10196-2     Document Type: Article

References (34)

1. 1. (a) Birkenmeyer, R.D.; Magerlein, B.J.; Kagan, F. Antimicrob. Ag. Chemother. 1966, 727.
2. (b) Birkenmeyer, R.D.; Kagan, F. J. Med. Chem. 1970, 13, 616.
3. (c) Magerlein, B.J.; Kagan, F. J. Med. Chem. 1969, 12, 780.
4. 2. (a) Kucers, A., Bennett, N. McK.; Kemp, R.J. In The Use of Antibiotics Lippincott: Philadelphia, 1987, pp 819-850.
5. (b) Blais, J., Tardif, C.; Chamberland, S. Antimicrob. Agts. Chemother. 1993, 37, 2571.
6. (c) Beckers, C.J.M.; Roos, D.S.; Donald, R.G.K.; Luft, B.J.; Schwab, J.C.; Cao, Y. J. Clin. Invest. 1995, 95, 367.
7. (d) Black, J.R.; Feinberg, J.; Murphy, R.L.; Fass, R.J.; Carey, J.; Sattler, F.R. Eur. J. Clin. Microbiol. Infect. Dis. 1991, 10, 204.
8. (e) Kremsner, P.O. J. Antimicrob. Chemother. 1990, 25, 9.
9. 3. (a) Chang, F.N.; Weisblum, B. Biochemistry 1967, 6, 836.
10. (b) Weisblum, B.; Davies, J.E. Bacteriol. Rev. 1968, 32, 493.
11. 4. (a) Magerlein, B.J. Adv. Appl. Microbiol. 1971, 14, 185.
12. (b) Morozowich, W. U.S. Patent No. 3,853,843 1974, pp 27.
13. (c) Birkenmeyer, R.D.; Kroll, S.J.; Lewis, C.; Stern, K.F.; Zurenko, G.E. J. Med. Chem. 1984, 27, 216.
14. 5. Douthwaite, S. Nucleic Acid Res. 1992, 20, 4717.
15. 6. (a) Mozad, F.; Noller, H.F. Nature, 1989, 342, 142.
16. (b) Kirillov, S.; Porse, B.T.; Vester, B., Woolley, P.; Garrett, R.A. FEBS Letters, 1997, 406, 223 and references therein.
17. 7. (a) Celma, M.L.; Monro, R.E.; Vazquez, D. FEBS Letters 1970, 6, 273.
18. (b) Celma, M.L.; Monro, R.E.; Vazquez, D. FEBS Letters 1971, 13, 247.
19. (c) Monro, R.E.; Fernandez-Munoz, R.; Celma, M.L.; Vazquez, D. Drug Action Drug Resist. Bact. 1971, 7, 305.
20. 8. (a) Menninger, J.R.; Coleman, R.A. Antimicrob. Agts. Chemother. 1993, 37, 2027.
21. (b) Menninger, J.R.; Coleman, R.A.; Tsai, L.N. Mol. Gen. Genet. 1994, 243, 225.
22. (c) Terakoka, H.; Tanaka, K.; Tamaki, M. Biochem. Biophys. Acta 1969, 174, 776.
23. 9. Nierhaus, K.H. In Perspectives in Biochemistry; Neurath, H., Ed.; American Chemical Society: Washington, D.C., 1991; Vol. 2, pp 220-231.
24. 10. (a) Harris, R.J.; Symons, R.H. Bioorg. Chem. 1973, 2, 266.
25. (b) Cheney, B.V. J. Med. Chem. 1974, 17, 590.
26. (c) Wilhelm, J.M.; Oleinick, N.L., Corcoran, J.W. Antimicrob. Agts. Chemother. 1967, 236.
27. 11. Yonath, A. In Nucleic Acids and Molecular Biology; Eckstein, F.; Lilley, D.M J., Eds.; Springer-Verlag: New York, 1992, Vol. 6, pp 134-147.
28. 12. Hanessian, S.; Sato, K.; Liak, T.J.; Danh, N.; Dixit, D. J. Am. Chem. Soc. 1984, 106, 6114.
29. 13. Goth, A. In Medical Pharmacology C.V. Mosby: St. Louis, 1978, pp 7-26.
30. 14. Watson, J.D. Bull. Soc. Chim. Biol. 1964, 46, 1399.
31. 15. Parfenov, D.V.; Saminsky, E.M. Mol. Biol. 1985, 19, 1130.
32. 16. Kallia-Raftopoulos, S.; Kalpaxis, D.L.; Coutsogeorgopoulos, C. Arch. Biochem. Biophys. 1992, 298, 332.
33. 17. (a) Orgel, L.E. Scientific American 1994, 277, 76.
34. (b) Mojzsis, S.J; Arrhenius, G.; McKeegan, K.D.; Harrison, T.M.; Nutman, A.P.; Friend, C.R. Nature, 1996, 384, 55.